- Previous Close
0.0050 - Open
0.0050 - Bid 0.0050 x --
- Ask --
- Day's Range
0.0050 - 0.0050 - 52 Week Range
0.0050 - 0.0100 - Volume
2,000 - Avg. Volume
5,035 - Market Cap (intraday)
548,940 - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also provides medical cannabis and other alternative treatments for various medical ailments through its clinic. The company is headquartered in Toronto, Canada.
optimindpharma.com--
Full Time Employees
February 29
Fiscal Year Ends
Sector
Recent News: OMND.CN
View More
Performance Overview: OMND.CN
Trailing total returns as of 3/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OMND.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OMND.CN
View MoreValuation Measures
Market Cap
548.94k
Enterprise Value
572.00k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.94
Price/Book (mrq)
--
Enterprise Value/Revenue
5.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-38.87%
Return on Equity (ttm)
-2,694.02%
Revenue (ttm)
111.33k
Net Income Avi to Common (ttm)
-895.12k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
102.58k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-76.32k
Company Insights: OMND.CN
OMND.CN does not have Company Insights